Topics

Dermira to Report First Quarter 2019 Results and Host Conference Call on Tuesday, May 7, 2019

16:05 EDT 30 Apr 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of people living with chronic skin conditions, ...

Other Sources for this Article

Media:
Erica Jefferson
Vice President, Corporate Communications
650-421-7216
media@dermira.com

Investors:
Andrew Guggenhime
Chief Financial Officer
650-421-7200
investor@dermira.com

NEXT ARTICLE

More From BioPortfolio on "Dermira to Report First Quarter 2019 Results and Host Conference Call on Tuesday, May 7, 2019"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...